Investigation Overview
An investigation on behalf of investors, who currently hold shares of Bioverativ Inc (NASDAQ:BIVV), was announced concerning whether the takeover of Bioverativ Inc. by Sanofi is unfair to NASDAQ:BIVV stockholders. The investigation by a law firm concerns whether certain officers and directors of Bioverativ Inc breached their fiduciary duties owed to NASDAQ:BIVV investors in connectio...
You must register (for free) or login to view the entire investigation.